empagliflozin and semaglutide Explore featured topics Editors' Picks from #JACCJournals, such as the consistent renal benefit with in #T2D/#CKD, late pericardial effusion post-#LAAO, & more, in the latest issue of #CardiologyMag. Read #JACC Effects of semaglutide and empagliflozin

Experimental Gerontology, 133, 110875

is an employee of and shareholder in New Zealand Clinical Research

Across different modalitiesincluding caloric restriction, exercise-based interventions, pharmacological agents, and bariatric surgeryweight reduction has been shown to result in bone loss, reduced BMD, and compromised bone quality

billed via G0108/G0109 Smoking cessation: Critical smoking dramatically accelerates all DM macrovascular and microvascular complications Pharmacologic Targets (ADA 2026) A1C target: 20): Finerenone (non-steroidal MRA), SGLT-2 inhibitors per ADA 2026 updated CKD recommendations Monitoring Technologies Continuous glucose monitoring (CGM): ADA 2026 Recommendation 13.5 recommended for all Type 1 DM

How can Generations Family Practice provide safe, personalized care and support patients in Cary, NC, using semaglutide GLP-1 injections to achieve effective weight loss